Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 18, 1996

View Archived Issues

Beta-blocker treatment reduces fatal post-surgical heart attack

Novel GABA uptake inhibitors from Novo Nordisk

Dainippon describes agents that act selectively on peripheral benzodiazepine receptors

Antiangiogenic compounds described by Taiho

Sandoz reports on tetraline derivatives for neurological disorders

Mercian discloses novel antitumor anthracycline antibiotics

Carbapenem esters revealed by SKB

Company Profile: Arris

Company Profile: Bone Care International

ML-3000 progresses through the pipeline

Piliel enters pivotal trials in Europe

Pamidronate effective against skeletal complications in breast cancer patients

Troglitazone hypotensive, hypoglycemic activities established in preclinical model

Corvas and Schering-Plough expand antithrombotic collaboration

Positive results reported for group A Streptococcus vaccine

Beacon obtains rights to Centocor tumor markers

Biovail grants another license for diltiazem product

New alopecia Rx tested in patients

Anti-L-selectin aptamers demonstrate efficacy in animals

Molecular Biosystems and Mallinckrodt expand contrast agent agreement

Shaman and Ono expand diabetes collaboration

GLA effective in treating active rheumatoid arthritis

Sankyo product pipeline in review

Chemopreventive effects of Targretin in breast cancer

Ciba/Sandoz merger approved

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...